Lexaria Total Assets from 2010 to 2024

LEXXW Stock

USD 0.75 0.04 5.63%

Lexaria Bioscience Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2005-11-30

Previous Quarter

10 M

Current Value

8.9 M

Quarterly Volatility

3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.

Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Total Assets Growth Pattern

Below is the plot of the Total Assets of Lexaria Bioscience Corp over the last few years. Total assets refers to the total amount of Lexaria Bioscience assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Lexaria Bioscience Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Lexaria Bioscience's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 8.87 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Lexaria Total Assets Regression Statistics

	Arithmetic Mean	4,267,657
	Geometric Mean	2,848,338
	Coefficient Of Variation	88.82
	Mean Deviation	2,961,211
	Median	2,860,178
	Standard Deviation	3,790,657
	Sample Variance	14.4T
	Range	12.7M
	R-Value	0.65
	Mean Square Error	9T
	R-Squared	0.42
	Significance	0.01
	Slope	548,487
	Total Sum of Squares	201.2T

Lexaria Total Assets History

	2024	9.3 M
	2023	8.9 M
	2022	3.1 M
	2021	7.8 M
	2020	13.3 M
	2019	2.8 M
	2018	2.7 M

Other Fundumenentals of Lexaria Bioscience Corp

Intangibles To Total Assets

Lexaria Bioscience Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Current Deferred Revenue	Net Receivables	Short Term Debt	Intangible Assets	Long Term Debt	Capital Surpluse	Property Plant Equipment	Net Invested Capital	Net Working Capital	Short Term Investments	Capital Stock	Short Long Term Debt
Total Assets		0.99	-0.9	-0.66	0.51	0.31	0.95	-0.55	-0.54	0.49	-0.19	0.67	-0.57	0.64	0.69	0.82	0.69	0.75	-0.81	-0.49
Total Stockholder Equity	0.99		-0.95	-0.69	0.46	0.16	0.98	-0.51	-0.6	0.46	-0.28	0.7	-0.62	0.68	0.7	0.86	0.73	0.81	-0.83	-0.45
Net Debt	-0.9	-0.95		0.68	-0.43	0.1	-0.99	0.38	0.55	-0.36	0.42	-0.68	0.66	-0.68	-0.67	-0.84	-0.72	-0.79	0.79	0.43
Retained Earnings	-0.66	-0.69	0.68		-0.68	-0.12	-0.71	0.29	0.48	-0.39	0.59	-0.93	0.82	-0.88	-0.91	-0.36	-0.15	-0.34	0.84	0.6
Accounts Payable	0.51	0.46	-0.43	-0.68		0.54	0.5	-0.4	0.07	-0.02	-0.2	0.46	-0.39	0.38	0.54	0.04	-0.19	-0.09	-0.59	-0.94
Total Liab	0.31	0.16	0.1	-0.12	0.54		0.05	-0.44	0.16	0.15	0.39	0.03	0.13	-0.06	0.1	-0.09	-0.19	-0.18	-0.17	-0.47
Total Current Assets	0.95	0.98	-0.99	-0.71	0.5	0.05		-0.45	-0.55	0.41	-0.37	0.7	-0.65	0.68	0.7	0.84	0.7	0.78	-0.82	-0.49
Common Stock	-0.55	-0.51	0.38	0.29	-0.4	-0.44	-0.45		0.59	0.15	-0.32	-0.32	-0.11	-0.08	-0.23	-0.49	-0.41	-0.4	0.72	0.33
Current Deferred Revenue	-0.54	-0.6	0.55	0.48	0.07	0.16	-0.55	0.59		-0.26	0.2	-0.63	0.32	-0.49	-0.46	-0.72	-0.7	-0.77	0.75	-0.13
Net Receivables	0.49	0.46	-0.36	-0.39	-0.02	0.15	0.41	0.15	-0.26		-0.2	0.48	-0.52	0.6	0.53	0.39	0.35	0.47	-0.21	0.02
Short Term Debt	-0.19	-0.28	0.42	0.59	-0.2	0.39	-0.37	-0.32	0.2	-0.2		-0.47	0.6	-0.52	-0.45	-0.18	-0.1	-0.21	0.31	0.19
Intangible Assets	0.67	0.7	-0.68	-0.93	0.46	0.03	0.7	-0.32	-0.63	0.48	-0.47		-0.8	0.96	0.92	0.44	0.3	0.48	-0.82	-0.33
Long Term Debt	-0.57	-0.62	0.66	0.82	-0.39	0.13	-0.65	-0.11	0.32	-0.52	0.6	-0.8		-0.9	-0.78	-0.3	-0.17	-0.35	0.56	0.35
Capital Surpluse	0.64	0.68	-0.68	-0.88	0.38	-0.06	0.68	-0.08	-0.49	0.6	-0.52	0.96	-0.9		0.9	0.4	0.28	0.48	-0.67	-0.27
Property Plant Equipment	0.69	0.7	-0.67	-0.91	0.54	0.1	0.7	-0.23	-0.46	0.53	-0.45	0.92	-0.78	0.9		0.43	0.24	0.44	-0.73	-0.49
Net Invested Capital	0.82	0.86	-0.84	-0.36	0.04	-0.09	0.84	-0.49	-0.72	0.39	-0.18	0.44	-0.3	0.4	0.43		0.96	0.96	-0.65	-0.09
Net Working Capital	0.69	0.73	-0.72	-0.15	-0.19	-0.19	0.7	-0.41	-0.7	0.35	-0.1	0.3	-0.17	0.28	0.24	0.96		0.96	-0.48	0.16
Short Term Investments	0.75	0.81	-0.79	-0.34	-0.09	-0.18	0.78	-0.4	-0.77	0.47	-0.21	0.48	-0.35	0.48	0.44	0.96	0.96		-0.6	0.09
Capital Stock	-0.81	-0.83	0.79	0.84	-0.59	-0.17	-0.82	0.72	0.75	-0.21	0.31	-0.82	0.56	-0.67	-0.73	-0.65	-0.48	-0.6		0.52
Short Long Term Debt	-0.49	-0.45	0.43	0.6	-0.94	-0.47	-0.49	0.33	-0.13	0.02	0.19	-0.33	0.35	-0.27	-0.49	-0.09	0.16	0.09	0.52

Click cells to compare fundamentals

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	8.9 M	9.3 M
Intangibles To Total Assets	0.06	0.06

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC